Meet Sarah DiSalvatore, passionate about bringing gene therapies to patients with rare diseases!
Sarah has more than 25 years of experience in research and development; including scientific research, clinical project management, process development and the implementation and execution of early phase and multi-national clinical trials. Additional roles have included vendor management and relationships, governance structure, business development discussions with potential partners and the engagement of venture capital firms to secure funding. Most recently, Sarah was employed with Rocket Pharma as AVP, Clinical Operations leading global clinical trials in rare diseases using gene therapy.